Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Nargiza Parpieva

49 ta ish

University College London

  1. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

    Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

    MaqolaTuberculosis Research and EpidemiologyNew England Journal of Medicine20225 iqtibos
    ABI

  2. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study

    Jamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov +14

    MaqolaTuberculosis Research and EpidemiologyPLoS ONE20154 iqtibos
    ABI

  3. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Jane Greig +5

    MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20164 iqtibos
    ABI

  4. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    James M. Trauer, Jay Achar, Nargiza Parpieva +7

    MaqolaTuberculosis Research and EpidemiologyBMC Medicine20163 iqtibos
    ABI

  5. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Nell Gray +5

    MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 iqtibos
    ABI

  6. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

    Parvati Nair, T. Hasan, K. K. Zaw +9

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20223 iqtibos
    ABI

  7. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan

    Beverley Stringer, Karen Lowton, Mirzagaleb N. Tillashaikhov +5

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20162 iqtibos
    ABI

  8. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

    Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos
    ABI

  9. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

    Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos
    ABI

  10. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 iqtibos
    ABI

  11. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    MaqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos
    ABI

  12. Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia

    A. Engström, Uladzimir Antonenka, Abdylat Kadyrov +10

    MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20191 iqtibos
    ABI

  13. Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?

    Ruzilya Usmanova, Nargiza Parpieva, Hayk Davtyan +6

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos
    ABI

  14. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

    Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos
    ABI

  15. Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–2017

    Sherali Massavirov, Kristina Akopyan, Fazlkhan Abdugapparov +5

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos
    ABI

  16. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

    Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

    MaqolaTuberculosis Research and EpidemiologyERJ Open Research20201 iqtibos
    ABI

  17. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Jay Achar, Nell Gray +4

    MaqolaTuberculosis Research and EpidemiologyPLoS ONE20201 iqtibos
    ABI

  18. Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan

    Fazlkhan Abdugapparov, Ruzanna Grigoryan, Nargiza Parpieva +7

    MaqolaPleural and Pulmonary DiseasesInternational Journal of Environmental Research and Public Health20211 iqtibos
    ABI

  19. [Features of disruption of certain components of carbohydrate metabolism in a combination of pulmonary tuberculosis and diabetes mellitus in people with haptoglobin phenotypes].

    Nargiza Parpieva, K S Kazakov

    MaqolaErythrocyte Function and PathophysiologyPubMed20010 iqtibos
    ABI

  20. Mutations in the genes of drug-resistant mycobacterium tuberculosis in Uzbekistan

    Nargiza Parpieva, Vera Beloserkoves, Khasan Safaev +1

    MaqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20140 iqtibos
    ABI

  21. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

    Jay Achar, Catherine Berry, Krzysztof Herboczek +7

    BoshqaTuberculosis Research and EpidemiologyEmerging infectious diseases20150 iqtibos
    ABI

  22. Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan

    Jamshid Gadoev, Damin Asadov, Anthony Harries +9

    MaqolaTuberculosis Research and EpidemiologyPLoS ONE20170 iqtibos
    ABI

  23. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

    Mathieu Bastard, Elisabeth Sánchez-Padilla, Philipp du Cros +12

    MaqolaTuberculosis Research and EpidemiologyPLoS ONE20180 iqtibos
    ABI

  24. Surgical approach in multi- and extensively drug-resistant tuberculosis: resection and thoracomioplasty

    Askar Zetov, Kulakhmed Erimbetov, Nargiza Parpieva +2

    MaqolaTuberculosis Research and EpidemiologyElectronic Journal of General Medicine20190 iqtibos
    ABI

  25. The center for distance learning and monitoring in education of tb specialists and medical students

    Sanajr Sultanov, Nargiza Parpieva, Kozim Mukhamedov

    MaqolaEconomic and Industrial Development20190 iqtibos
    ABI